Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 4:16 pm Unchanged | 2024-12-31 | 13G | Lumos Pharma, Inc. LUMO | Private Advisor Group LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-02-13 4:02 pm Unchanged | 2024-12-31 | 13G | Lumos Pharma, Inc. LUMO | GOLDMAN SACHS GROUP INC GS | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-12 6:27 pm Unchanged | 2024-11-12 | 13G | Lumos Pharma, Inc. LUMO | Private Advisor Group LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-10-25 10:43 am Purchase | 2024-09-30 | 13G | Lumos Pharma, Inc. LUMO | WELLS FARGO & COMPANY WFC | 64,981 0.800% | 64,981 (New Position) | Filing History |
| 2024-02-09 7:14 pm Unchanged | 2024-02-09 | 13G | Lumos Pharma, Inc. LUMO | GOLDMAN SACHS GROUP INC GS | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-06 09:57 am Unchanged | 2024-02-06 | 13G | Lumos Pharma, Inc. LUMO | WELLS FARGO & COMPANY WFC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-11-29 4:30 pm Unchanged | 2023-11-29 | 13D | Lumos Pharma, Inc. LUMO | Blackstone Holdings II L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-06-20 06:05 am Sale | 2023-06-16 | 13D | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 400,000 4.900% | -96,891 (-19.50%) | Filing History |
| 2023-06-02 11:14 am Sale | 2023-05-30 | 13D | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 496,891 6.080% | -146,447 (-22.76%) | Filing History |
| 2023-05-25 12:10 pm Sale | 2023-05-24 | 13D | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 643,338 7.870% | -116,662 (-15.35%) | Filing History |
| 2023-02-14 6:25 pm Unchanged | 2023-02-13 | 13D | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 760,000 9.070% | 0 (Unchanged) | Filing History |
| 2023-02-06 5:43 pm Purchase | 2022-12-30 | 13G | Lumos Pharma, Inc. LUMO | GOLDMAN SACHS GROUP INC GS | 469,402 5.600% | 469,402 (New Position) | Filing History |
| 2023-01-24 12:58 pm Purchase | 2023-01-25 | 13G | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 760,000 9.070% | 263,189 (+52.98%) | Filing History |
| 2022-02-02 2:44 pm Unchanged | 2022-01-27 | 13G | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 496,811 5.940% | 0 (Unchanged) | Filing History |
| 2022-01-31 5:34 pm Purchase | 2022-01-27 | 13G | Lumos Pharma, Inc. LUMO | Farb Daniel Stuart | 496,811 5.940% | 496,811 (New Position) | Filing History |
| 2022-01-05 2:41 pm Sale | 2021-12-27 | 13D | Lumos Pharma, Inc. LUMO | New Enterprise Associates 14 L.P. | 0 0.000% | -524,030 (Position Closed) | Filing History |
| 2021-08-30 5:21 pm Purchase | 2021-08-20 | 13D | Lumos Pharma, Inc. LUMO | SHV Management Services II LP | 679,909 8.100% | 679,909 (New Position) | Filing History |
| 2021-05-26 3:53 pm Sale | 2021-03-22 | 13G | Lumos Pharma, Inc. LUMO | Flynn James E | 161,714 1.940% | -774,577 (-82.73%) | Filing History |